Jingwei Qili is one of the earliest companies in China to enter the field of independent R&D, large-scale production, and volume sales of FPGA chips and heterogeneous programmable computing chips. The company has mass-produced multiple programmable FPGA chips, including the low-cost SoC "Shan" series (HME-M), the low-power "He" series (HME-R), and the high cost-performance "Hercules" series (HME-H). It is currently mass-producing the high-capacity, high-performance "Pegasus" series (HME-P) FPGA chips.
Jingwei Qili has collaborated with multiple companies to apply its mass-produced products in medical equipment, broadcast equipment, and optical instruments, supporting the frontline fight against the epidemic. The aforementioned instruments and equipment utilize our HME-M5 and HME-M7 series FPGA chips to implement functions such as display, video image processing, transmission, and distance measurement. Among them, the ECG monitor developed by a Beijing customer and the blood cell analyzer developed by a Jinan customer have already been deployed in major hospitals; in addition, the total station developed by a Jiangsu customer played an important role in the construction of the Huoshenshan and Leishenshan hospitals. During this period, Jingwei Qili overcame difficulties to prioritize guaranteeing production supply for these customers, working together with them to contribute its modest efforts to the fight against the epidemic.
In addition, as one of the portfolio companies invested by Inno Angel Fund, Jingwei Qili joined other companies in donating funds designated for combating the epidemic, which were donated to the Beijing Charity Association and the Hubei Charity Federation to support epidemic prevention and control efforts.
United in purpose, we fight the epidemic together — we are with you!
